GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Resmed Inc. (RMD) [hlAlert]

Rating:
Hold RMD

Resmed Inc. (RMD) rated Hold with price target $40 by Feltl & Co.

Posted on: Monday,  Aug 6, 2012  6:56 PM ET by Feltl & Co.

Feltl & Co. rated Hold Resmed Inc. (NYSE: RMD) on 08/06/2012. Previously Feltl & Co. rated Buy Resmed Inc. (NYSE: RMD) on
04/27/2012., when the stock price was $34.03. Since then, Resmed Inc. has lost 5.94% as of 07/19/2012's recent price of $32.01.
If you would have followed the previous Feltl & Co.'s recommendation on RMD, you would have lost 5.93% of your investment in 83 days.

ResMed Inc. is a holding company. Through its subsidiaries, the Company develops, manufactures and distributes medical equipment for treating, diagnosing and managing sleep-disordered breathing (SDB) and other respiratory disorders, including obstructive sleep apnea (OSA). It has developed nasal continuous positive airway pressure (CPAP) as a non-invasive treatment for OSA. CPAP systems deliver pressurized air, typically through a nasal mask, to prevent collapse of the upper airway during sleep. The Company has developed a number of products for SDB and other respiratory disorders, including airflow generators, diagnostic products, mask systems, headgear and other accessories. ResMed Inc. sells its products in over 70 countries through a combination of wholly owned subsidiaries and independent distributors to sleep clinics, home healthcare dealers and third-party payers. On April 30, 2009, it acquired Respicure Medsys PVT.LTD. In October 2009, ResMed Inc. acquired Laboratoires Narval.

Feltl and Company's Research Department is focused on micro to small market capitalization companies that are not widely covered by other research firms. Our research universe is focused and organized around the sectors of Technology, HealthCare, and Leisure/Consumer. Feltl and Company holds its research department to very high standards, and strives to provide value- added investment ideas through sound fundamental analysis. Feltl and Company's Research Department includes six senior analysts and one associate analyst with many years of investment analysis experience. Although we are focused on, and committed to, companies in the Upper Midwest, our reach extends from coast to coast. About half of the companies we cover are headquartered outside our "backyard." Our analysts have significant industry experience and strive to know their companies inside and out. Through stringent analysis, they provide value by creating a disciplined application of company valuation, allowing our clients to make sound investment decisions.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
8/6/2012 6:56 PM Hold
None
35.61 40.00
as of 12/31/2012
1 Week   
1 Month   
3 Months   
1 YTD up  16.07 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
7/19/2012 9:27 AM Hold
None
32.01 35.75
4/27/2012 9:25 AM Buy
None
34.03 38.00
3/28/2012 9:25 AM Hold
None
30.99
1/17/2012 9:25 AM Buy
None
26.26 33.15
12/20/2011 8:25 AM Buy
None
25.08 35.00
10/25/2011 10:25 AM Buy
None
27.78 39.10
6/30/2011 9:25 AM Buy
None
31.16 40.40

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy